ShopSpell

Antibiotics: The Perfect Storm [Paperback]

$86.99     $109.99   21% Off     (Free Shipping)
9,999 available
  • Category: Books (Medical)
  • Author:  Shlaes, David M.
  • Author:  Shlaes, David M.
  • ISBN-10:  9400795327
  • ISBN-10:  9400795327
  • ISBN-13:  9789400795327
  • ISBN-13:  9789400795327
  • Publisher:  Springer
  • Publisher:  Springer
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Mar-2014
  • Pub Date:  01-Mar-2014
  • SKU:  9400795327-11-SPRI
  • SKU:  9400795327-11-SPRI
  • Item ID: 100948910
  • List Price: $109.99
  • Seller: ShopSpell
  • Ships in: 2 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 28 to Oct 30
  • Notes: Brand New Book. Order Now.

Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Since bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have today, and because they will ultimately become resistant to any antibiotic that we use for treatment or for anything else, we need a steady supply of new antibiotics active against any resistant bacteria that arise. However, the antibiotics marketplace is no longer attractive for large pharmaceutical companies, the costs of development are skyrocketing because of ever more stringent requirements by the regulatory agencies, and finding new antibiotics active against resistant strains is getting harder and harder. These forces are all combining to deny us these miracle drugs when we need them the most. I provide a number of possible paths to shelter from this perfect storm.While antibiotics protect against infectious disease, disease-causing bacteria continue to build resistance and threaten the effectiveness of current drugs. Antibiotics explores this process and provides alternative approaches to reduce this growing problem.Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Since bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have today, and because they will ultimately become resistant to any antibiotic that we use for treatment or for anything else, we need a steady supply of new antibiotics active against any resistant bacteria that arise. However, the antibiotics marketplace is no longer attractive for large pharmaceutical companies, the costs of development are skyrocketing because of ever more stringent requirements by the regulatory agencies, and finding new antibiotics activelƒ1

Add Review